Events

EIT Raw Materials Summit 2026
MAY
Tue
19
MAY
Wed
20

Starts in 3 months from now

Location

Brussels

Programmes
Digital, Industry & Space EIT

The 8th EIT raw materials Summit brings together the full value chain and public–private capital from the sector of European raw materials production. Over two days, the event will explore the five key pillars driving Europe's future competitiveness: 

  • Strategic initiatives for domestic extraction and processing
  • Circular economy advancements in recycling and secondary raw materials
  • Global materials diplomacy aligned with EU trade goals
  • Innovation in scaling technologies and structuring finance
  • Building the workforce needed for 2030 through education and upskilling.

The participitants will come from all corners of the ecosystem surrounding the European Institute of Innovation and Technology (EIT) and there is plenty of room for networking. You can already register for updates about this event on the website.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.